Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kohn

Showing results (51-60 of 369) with videos related to

Pageof 37
Sort By:
IARC Scientific Publications|August 24, 1999
Possible mechanisms of induction of renal tubule cell neoplasms in rats associated with alpha 2u-globulin: role of protein accumulation versus ligand delivery to the kidneyR L Melnick, M C Kohn
Drug Metabolism Reviews|April 25, 2000
Dose-response analyses of experimental cancer dataR L Melnick, M C Kohn
Gynecologic Oncology|December 8, 2017
Clinical trials in gynecologic oncology: Past, present, and futureChristina M Annunziata, Elise C Kohn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implicationsL R Duska, E C Kohn
Cancer|July 16, 2008
Rationale for combination use of targeted agents in ovarian cancer: do we have one?Robert L Coleman, Elise C Kohn
Chemico-Biological Interactions|June 9, 2001
Physiological modeling of butadiene disposition in mice and ratsM C Kohn, R L Melnick
Journal of the National Cancer Institute|August 8, 2002
Stromal therapy: the next step in ovarian cancer treatmentLance A Liotta, Elise C Kohn
Gynecologic Oncology|June 25, 2003
Is there a genomic basis for primary chemoresistance in ovarian cancer?Christina M Annunziata, Elise C Kohn
Veterinary Pathology|July 1, 1983
Erythrocyte volume distribution analysis and hematologic changes in two horses with immune-mediated hemolytic anemiaG Weiser, C Kohn, A Vachon
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Proteomics as a guiding tool for more effective personalized therapyJ-M Lee, E C Kohn
Pageof 37

Showing results (51-60 of 369) with videos related to

Sort By:
Pageof 37
IARC Scientific Publications|August 24, 1999
Possible mechanisms of induction of renal tubule cell neoplasms in rats associated with alpha 2u-globulin: role of protein accumulation versus ligand delivery to the kidneyR L Melnick, M C Kohn
Drug Metabolism Reviews|April 25, 2000
Dose-response analyses of experimental cancer dataR L Melnick, M C Kohn
Gynecologic Oncology|December 8, 2017
Clinical trials in gynecologic oncology: Past, present, and futureChristina M Annunziata, Elise C Kohn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implicationsL R Duska, E C Kohn
Cancer|July 16, 2008
Rationale for combination use of targeted agents in ovarian cancer: do we have one?Robert L Coleman, Elise C Kohn
Chemico-Biological Interactions|June 9, 2001
Physiological modeling of butadiene disposition in mice and ratsM C Kohn, R L Melnick
Journal of the National Cancer Institute|August 8, 2002
Stromal therapy: the next step in ovarian cancer treatmentLance A Liotta, Elise C Kohn
Gynecologic Oncology|June 25, 2003
Is there a genomic basis for primary chemoresistance in ovarian cancer?Christina M Annunziata, Elise C Kohn
Veterinary Pathology|July 1, 1983
Erythrocyte volume distribution analysis and hematologic changes in two horses with immune-mediated hemolytic anemiaG Weiser, C Kohn, A Vachon
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Proteomics as a guiding tool for more effective personalized therapyJ-M Lee, E C Kohn
Pageof 37